- Home
- ABEO vs CLCO Comparison
ABEO vs CLCO Comparison
Compare ABEO & CLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- CLCO
- Stock Information
- Founded
- ABEO 1974
- CLCO 2018
- Country
- ABEO United States
- CLCO United Kingdom
- Employees
- ABEO N/A
- CLCO N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- CLCO
- Sector
- ABEO Health Care
- CLCO
- Exchange
- ABEO Nasdaq
- CLCO Nasdaq
- Market Cap
- ABEO 332.0M
- CLCO 360.2M
- IPO Year
- ABEO 1980
- CLCO N/A
- Fundamental
- Price
- ABEO $6.26
- CLCO $7.32
- Analyst Decision
- ABEO Strong Buy
- CLCO
- Analyst Count
- ABEO 6
- CLCO 0
- Target Price
- ABEO $18.00
- CLCO N/A
- AVG Volume (30 Days)
- ABEO 611.9K
- CLCO 62.3K
- Earning Date
- ABEO 08-19-2025
- CLCO 08-28-2025
- Dividend Yield
- ABEO N/A
- CLCO 8.24%
- EPS Growth
- ABEO N/A
- CLCO N/A
- EPS
- ABEO N/A
- CLCO 1.31
- Revenue
- ABEO N/A
- CLCO $320,759,000.00
- Revenue This Year
- ABEO N/A
- CLCO $2.10
- Revenue Next Year
- ABEO $322.37
- CLCO N/A
- P/E Ratio
- ABEO N/A
- CLCO $5.55
- Revenue Growth
- ABEO N/A
- CLCO N/A
- 52 Week Low
- ABEO $3.93
- CLCO $4.51
- 52 Week High
- ABEO $7.32
- CLCO $12.41
- Technical
- Relative Strength Index (RSI)
- ABEO 47.50
- CLCO 58.43
- Support Level
- ABEO $6.18
- CLCO $7.20
- Resistance Level
- ABEO $6.94
- CLCO $7.64
- Average True Range (ATR)
- ABEO 0.27
- CLCO 0.27
- MACD
- ABEO -0.05
- CLCO 0.03
- Stochastic Oscillator
- ABEO 18.07
- CLCO 69.05
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About CLCO Cool Company Ltd.
Cool Co Ltd is a LNG shipping company. The company is engaged in the acquisition, ownership, operation and chartering of liquefied natural gas (LNG) carriers (LNGCs), and the operation of third party fleets under management agreements. The company manages its business through a single operating and reporting segment, the LNG carrier market.